BioMarin Pharmaceutical Inc (BMRN) Revenue 2016–2025
BioMarin Pharmaceutical Inc (BMRN) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$3.2BFY2025 · since FY2016: $1.1B → $3.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.2B | +12.9% |
| FY2024 | $2.9B | +18.0% |
| FY2023 | $2.4B | +15.4% |
| FY2022 | $2.1B | +13.5% |
| FY2021 | $1.8B | -0.8% |
| FY2020 | $1.9B | +9.2% |
| FY2019 | $1.7B | +14.3% |
| FY2018 | $1.5B | +13.5% |
| FY2017 | $1.3B | +17.6% |
| FY2016 | $1.1B | — |
Source: SEC XBRL filings · For reference only · Not investment advice